 |
PDBsum entry 6ulh
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
376 a.a.
|
 |
|
|
|
|
|
|
|
145 a.a.
|
 |
|
|
|
|
|
|
|
76 a.a.
|
 |
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Structure of mavc in complex with its substrate in r3 spacegroup
|
|
Structure:
|
 |
Lpg2147 (mavc). Chain: a. Engineered: yes. Mutation: yes. Ubiquitin-conjugating enzyme e2 n. Chain: c. Synonym: bendless-like ubiquitin-conjugating enzyme,e2 ubiquitin- conjugating enzyme n,ubc13,ubch13,ubiquitin carrier protein n, ubiquitin-protein ligase n.
|
|
Source:
|
 |
Legionella pneumophila. Organism_taxid: 446. Gene: lpg2147. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Homo sapiens. Human. Organism_taxid: 9606. Gene: ube2n, blu.
|
|
Resolution:
|
 |
|
1.97Å
|
R-factor:
|
0.185
|
R-free:
|
0.227
|
|
|
Authors:
|
 |
S.Iyer,K.Puvar,C.Das
|
|
Key ref:
|
 |
K.Puvar
et al.
(2020).
Legionella effector MavC targets the Ube2N~Ub conjugate for noncanonical ubiquitination.
Nat Commun,
11,
2365.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Oct-19
|
Release date:
|
27-May-20
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q5ZTL4
(Q5ZTL4_LEGPH) -
MvcA insertion domain-containing protein from Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
482 a.a.
376 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain C:
E.C.2.3.2.23
- E2 ubiquitin-conjugating enzyme.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L- cysteine
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Commun
11:2365
(2020)
|
|
PubMed id:
|
|
|
|
|
| |
|
Legionella effector MavC targets the Ube2N~Ub conjugate for noncanonical ubiquitination.
|
|
K.Puvar,
S.Iyer,
J.Fu,
S.Kenny,
K.I.Negrón Terón,
Z.Q.Luo,
P.S.Brzovic,
R.E.Klevit,
C.Das.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The bacterial effector MavC modulates the host immune response by blocking Ube2N
activity employing an E1-independent ubiquitin ligation, catalyzing formation of
a γ-glutamyl-ε-Lys (Gln40Ub-Lys92Ube2N) isopeptide
crosslink using a transglutaminase mechanism. Here we provide biochemical
evidence in support of MavC targeting the activated, thioester-linked
Ube2N~ubiquitin conjugate, catalyzing an intramolecular transglutamination
reaction, covalently crosslinking the Ube2N and Ub subunits effectively
inactivating the E2~Ub conjugate. Ubiquitin exhibits weak binding to MavC alone,
but shows an increase in affinity when tethered to Ube2N in a disulfide-linked
substrate that mimics the charged E2~Ub conjugate. Crystal structures of MavC in
complex with the substrate mimic and crosslinked product provide insights into
the reaction mechanism and underlying protein dynamics that favor transamidation
over deamidation, while revealing a crucial role for the structurally unique
insertion domain in substrate recognition. This work provides a structural basis
of ubiquitination by transglutamination and identifies this enzyme's true
physiological substrate.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |